Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà, WEF Study Group – 13 January 2014 – We assessed the cost‐effectiveness of sofosbuvir (SOF)‐based triple therapy (TT) compared with boceprevir (BOC)‐ and telaprevir (TVR)‐based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source.

Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà, WEF Study Group – 13 January 2014 – We assessed the cost‐effectiveness of sofosbuvir (SOF)‐based triple therapy (TT) compared with boceprevir (BOC)‐ and telaprevir (TVR)‐based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source.

Mauro Viganò, y Pietro Lampertico – 13 January 2014 – Watch a video presentation of this article

Andres F. Carrion,, y Paul Martin, – 13 January 2014 – Watch a video presentation of this article

Thomas D. Boyer, y Bruce Kaplan – 13 January 2014 – Watch a video presentation of this article

Asmeen Bhatt, y Gregory T. Everson – 13 January 2014 – Watch a video presentation of this article

Asmeen Bhatt, y Gregory T. Everson – 13 January 2014 – Watch a video presentation of this article

Edoardo G. Giannini, Franco Trevisani – 13 January 2014

Robert P. Perrillo – 13 January 2014 – Watch a video presentation of this article

Harjit K. Bhogal,, Arun J. Sanyal, – 13 January 2014 – Watch a video presentation of this article